Tag Archive | "Elan"

Partnering Agreements with Elan

Tags: ,

The Partnering Agreements with Elan report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. Read the full story

Perrigo seals deal with Elan company acquisition

Tags: , ,

Perrigo announced company acquisition of big biotech, Elan  under which Elan will be acquired by a new holding company incorporated in Ireland Read the full story

Will Allergan and Forest bid for Elan?

Tags: , , , ,

Sources suggest that Allergan and Forest will table rival bids to acquire Elan this week Read the full story

Biotech rumor mill: Game may not be over for Royalty’ Pharma’s bid for Elan

Tags: , , ,

In the biotech rumor mill: Sources stating that the game may not be over for Royalty' Pharma's bid for Elan. Read the full story

Biotech rumor mill: Forest Laboratories mulls bid for Irish drugmaker Elan

Tags: , , ,

According to the biotech rumor mill Forest Laboratories, a big pharma company, is among a handful of companies interested in bidding for Irish drugmaker Elan, a big biotech company.  Read the full story

Biotech rumour mill: Royalty Pharma drops hostile bid for Elan

Tags: , , ,

Royalty Pharma's hostile $8 billion bid for Irish drug firm Elan lapsed in the biotech rumour mill on Tuesday when it withdrew an appeal against a ruling by Ireland's regulator on takeover battles. Read the full story

Biotech rumour mill: Elan put itself on the market

Tags: ,

In the biotech rumour mill, Irish drug firm Elan, a big biotech company, puts itself up for sale. Read the full story

Elan receives $6.7 billion M&A offer from Royalty Pharma with options to the overall sum of $8 billion

Tags: , ,

Royalty Pharma has raised its bid for Elan again. With sum m&a value now sitting at $6.7 billion with options bringing the overall deal value to $8 billion. Read the full story

Elan big biotech deals Speranza Therapeutics for ELND005 license

Tags: , , ,

Elan has entered biotech deals and decides to divest ELND005 to, Speranza Therapeutics, focused on progressing the development of ELND005 (Scyllo-inositol). Read the full story

Elan’s senior notes financing placement for $800 million

Tags: , ,

Elan Corporation announced that its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp intend to offer for financing, subject to market conditions, US$800.0 million in aggregate principal amount of Senior Notes due 2021. Read the full story